Clinical trial
Supplementation With Hyaluronic Acid, Alpha-lipoic Acid, Magnesium, and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone: a Pilot Study.
NCT04874285 is registered in ClinicalTrials.gov with Lo.Li.Pharma s.r.l as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Supplementation With Hyaluronic Acid, Alpha-lipoic Acid, Magnesium, and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone: a Pilot Study.
- Lead sponsor
- Lo.Li.Pharma s.r.l
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 3, 2021
- Completion date
- May 11, 2023
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy, high risk